Valvular Heart Disease Clinical Trial
Official title:
Safety and Efficacy of the Gastric Reactance (XL) in the Prediction of Morbimortality in Patients Post-operated of Elective Cardiac Surgery
Verified date | January 2020 |
Source | Critical Perfusion Inc. |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Evaluate the safety and effectiveness of the XL trend measured by Florence (Critical
Perfusion Inc, Palo Alto, California) in the prediction of morbimortality of Mexican patients
post-operated of elective cardiovascular surgery.
Hypothesis: 1. The gastric reactance measurement (XL) correlates with the morbimortality
(postoperatory shock, excessive bleeding, vasoplegic syndrome and death) and with the risk
predictors (APACHE II, STS, SOFA, and EUROSCORE II) with patients post-operated of elective
cardiac surgery. 2. It is possible to identify the cut-off point of the values of the gastric
reactance (XL) as a predictive tool of morbimortality in patients post-operated of elective
cardiac surgery. 3. The gastric reactance (XL) is a safe measurement to patients undergoing
cardiac surgery.
Status | Completed |
Enrollment | 38 |
Est. completion date | December 28, 2019 |
Est. primary completion date | December 28, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Women and men within an age equal or greater than 18 years old. - Subjects scheduled to an elective cardiac surgery for valvular surgery, revascularization or a combination of both. - Subjects compliant with the indication to be placed a floating pulmonary artery catheter. - Marks results previous to surgery: STS mortality risk equal or greater than 6% of the day before or Euro Score II with a mortality risk equal or greater than 6% or left ventricle ejection fraction (LVEF/FEVI) less than 45% (patients with cardiac failure or right ventricle dysfunction or a combination of both), tricuspid annular plane systolic excursion (TAPSE) less than 17 mm, peak systolic velocity of tricuspid lateral ring measured by Tissue Doppler (LVOT/TSVI) less than 0.1 m/s; patient with elective surgery of: aortic and mitral valve replacement or aortic and mitral valve replacement + tricuspid valve plasty or aortic valve replacement + mitral valve plasty or mitral valve replacement + tricuspid valve plasty or aortic, mitral and tricuspid valve replacement or aortic valve replacement + tricuspid valve plasty or double valve replacement (any combination) + revascularization or aortic valve replacement + revascularization + mitral valve plasty. - Subject is not enrolled in another investigational protocol. - Informed consent has been signed of acceptance by the subject before study procedures. - Subject in sinus rhythm before surgery. Exclusion Criteria: - Subjects with records of recent digestive tube bleeding (last 30 days). - Paraplegic or hemiplegic subjects. - Subjects with congenital background (interauricular communication, ventricular atrial channel, coarctation of the aorta, persistent arterial duct, pulmonary stenosis, ventricular septal defect, tetralogy of fallot, total or partial anomalous pulmonary venous drainage, transposition of the great vessels, tricuspid atresia, arterial trunk, etc). - Maxillofacial malformation. - Catheter placement failure. - Known pregnancy or discovered pregnancy after admission (before surgery). - Woman in breastfeeding period. - Subjects not compliant with clinical indication of nasogastric catheter placement or contraindicated to place a nasogastric catheter. - Subjects with an implanted pacemaker or permanent defibrillator. - Medication supply that impedes contact between Florence catheter and the gastric mucosa (barrier effect) like sucralfate, aluminum hydroxide, bismuth subsalicylate, magaldrate, etc. |
Country | Name | City | State |
---|---|---|---|
Mexico | Instituto Nacional de Cardiología Ignacio Chávez | Tlalpan | Ciudad De México |
Lead Sponsor | Collaborator |
---|---|
Critical Perfusion Inc. | Alandra Medical SAPI de CV, Gerbera Capital, Instituto Nacional de Cardiologia Ignacio Chavez, National Council of Science and Technology, Mexico |
Mexico,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Correlation between gastric reactance (XL) and morbimortality and risk predictors | Multivariate analysis to observe variability between different events according to data distribution to determine how is affecting the risk scales, hemodynamic variables, lactate and mixed venous oxygen saturation, morbidity and mortality with central gastric reactance (XL). | 72 hours | |
Primary | Sensibility and specificity of the collected variables | ROC curves will be calculated to determine sensibility and specificity of the variables. | 72 hours | |
Primary | Adverse events tracing with the use of Florence catheter | Serious Adverse Device Effects and Adverse Events assessment to evaluate device safety. | 30 days | |
Secondary | Correlations between XL measurements and medication | Multivariate analysis to observe variability between different events according to data distribution to determine how is affecting XL with amines, proton-pump inhibitors, and anesthesia medications. | 72 hours | |
Secondary | Correlations between laboratory parameters and XL | Multivariate analysis to observe variability between different events according to data distribution to determine how is affecting XL with laboratory parameters. | 72 hours | |
Secondary | Usability of Florence device in a real environment. | Questionnaire for the nurse and/or the physician regarding the use of Florence device at the Operating Room and Intensive Care Unit. | 72 hours |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
Completed |
NCT02241109 -
Predicting Aortic Stenosis Progression by Measuring Serum Calcification Propensity
|
N/A | |
Completed |
NCT01676727 -
ADVANCE Direct Aortic Study
|
||
Completed |
NCT01476995 -
Prognostic Indicators as Provided by the EPIC ClearView
|
N/A | |
Completed |
NCT00721136 -
Randomized Study of the Use of Warfarin During Pacemaker or ICD Implantation in Patients Requiring Long Term Anticoagulation
|
N/A | |
Recruiting |
NCT05014750 -
Frailty of Elderly With Valvular Heart Disease and the Short Term Adverse Events
|
||
Recruiting |
NCT05044338 -
Study on Standard Evaluation System and Optimal Treatment Path of Senile Valvular Heart Disease
|
||
Recruiting |
NCT05015829 -
Diagnostic Impact of Low-dose Dobutamine Echocardiography in Low-flow Low-gradient Aortic Stenosis
|
||
Recruiting |
NCT05078619 -
Percutaneous Coronary Intervention Before Transcatheter Aortic Valve Implantation
|
N/A | |
Recruiting |
NCT06307262 -
European Registry of Transcatheter Repair for Tricuspid Regurgitation
|
||
Completed |
NCT01624870 -
CoreValve Advance-II Study: Prospective International Post-market Study
|
||
Completed |
NCT05708690 -
Topical Effect of Tranexamic Acid in Postoperative Bleeding and Blood Products Transfusion After Cardiac Surgery
|
Phase 4 | |
Recruiting |
NCT03797820 -
Multicenter Registry Study of Aortic Valve Stenosis in Zhejiang Elderly(Mrs AVS)
|
||
Recruiting |
NCT06077721 -
Milrinone on Right Ventricular Strain in Cardiac Surgery
|
||
Not yet recruiting |
NCT04632914 -
Effect of Trunk Stabilizing Exercises on Patients With Median Sternotomy After Heart Valve Surgery
|
N/A | |
Completed |
NCT01477151 -
Randomized Isoflurane and Sevoflurane Comparison in Cardiac Surgery
|
Phase 4 | |
Terminated |
NCT03590730 -
Benefits of ICD for the Primary Prevention in Patients With Valvular Cardiomyopathy
|
||
Recruiting |
NCT06204783 -
Real-time Pressure Volume Loop Monitoring as a Guide for Enhanced Understanding of Changes in Elemental Cardiovascular Physiology During Therapeutic Strategies Aiming for Hemodynamic Optimization. Cohort II: Structural Heart Interventions (PLUTO-II)
|
||
Enrolling by invitation |
NCT05775354 -
Reviving Early Diagnosis of Cardiovascular Disease in the Utrecht Health Project
|
N/A | |
Not yet recruiting |
NCT04301648 -
Impact in Quality of Care of the "STructural heARt NURSE" as New Interventional Cardiology Nursing Role in Spain.
|
N/A |